Proteomic characterization of blood-brain barrier surface receptors including transferrin receptor (TfR1), LRP1, TMEM30A, and related antibody transcytosis targets. Aggregated from BBB proteomics studies (Zuchero et al. 2016 Neuron, Tian et al. 2020) and the Human Protein Atlas brain vasculature section. Referenced in analyses of antibody BBB penetrance mechanisms for AD therapeutics.